Brain cancer fight: new combo drugs tested in key trial
NCT ID NCT04700072
Summary
This study tested new drug combinations for people with melanoma skin cancer that had spread to the brain. The goal was to find treatments that are safer and work better than current options. It involved 56 participants and measured how well the tumors shrank and how long the response lasted.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
A.P.H. Paris, Hopital Saint Louis ( Site 4107)
Paris, 75010, France
-
CANCERCARE LANGENHOVEN DRIVE ONCOLOGY CENTRE ( Site 4865)
Port Elizabeth, Eastern Cape, 6055, South Africa
-
CHU de Bordeaux- Hopital Saint Andre ( Site 4108)
Bordeaux, Gironde, 33075, France
-
CHUV Centre Hospitalier Universitaire Vaudois ( Site 4602)
Lausanne, Canton of Vaud, 1011, Switzerland
-
Calvary Mater Newcastle ( Site 4404)
Waratah, New South Wales, 2298, Australia
-
Cape Town Oncology Trials ( Site 4864)
Cape Town, Western Cape, 7570, South Africa
-
Centre Hospitalier Lyon Sud ( Site 4102)
Pierre-Bénite, Rhone, 69495, France
-
Chaim Sheba Medical Center ( Site 4701)
Ramat Gan, 5265601, Israel
-
Duke Cancer Institute ( Site 4005)
Durham, North Carolina, 27710, United States
-
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 4399)
Milan, 20133, Italy
-
Gustave Roussy ( Site 4101)
Villejuif, Île-de-France Region, 94805, France
-
HOSPITAL CLÍNIC DE BARCELONA-ICHMO- Clinic Institut of Haematological and Oncological diseases ( Site 4801)
Barcelona, Catalonia, 08036, Spain
-
HaEmek Medical Center ( Site 4703)
Afula, 1834111, Israel
-
Hadassah Ein Karem Jerusalem ( Site 4702)
Jerusalem, 9112001, Israel
-
Hopital La Timone ( Site 4103)
Marseille, Bouches-du-Rhone, 13005, France
-
Hospital Universitario Ramón y Cajal ( Site 4802)
Madrid, Madrid, Comunidad de, 28034, Spain
-
Hôpitaux Universitaires de Genève (HUG)-Oncology ( Site 4603)
Geneva, Canton of Geneva, 1211, Switzerland
-
Inova Schar Cancer Institute ( Site 4011)
Fairfax, Virginia, 22031, United States
-
Institut Claudius Regaud ( Site 4105)
Toulouse, Haute-Garonne, 31059, France
-
Istituto Europeo di Oncologia ( Site 4301)
Milan, 20141, Italy
-
Istituto Nazionale Tumori Fondazione Pascale ( Site 4302)
Naples, 80131, Italy
-
Istituto Oncologico Veneto IRCCS ( Site 4355)
Padua, 35128, Italy
-
LIFE GROENKLOOF-Mary Potter Cancer Centre ( Site 4861)
Pretoria, Gauteng, 0181, South Africa
-
Martha Morehouse Tower ( Site 4020)
Columbus, Ohio, 43221, United States
-
Melanoma Institute Australia ( Site 4402)
Wollstonecraft, New South Wales, 2065, Australia
-
NYU Clinical Cancer Center ( Site 4002)
New York, New York, 10016, United States
-
Policlinico Le Scotte - A.O. Senese ( Site 4377)
Siena, 53100, Italy
-
Providence Saint John's Health Center ( Site 4010)
Santa Monica, California, 90404, United States
-
Rabin Medical Center-Oncology ( Site 4705)
Petah Tikva, 4941492, Israel
-
Rambam Health Care Campus-Oncology ( Site 4704)
Haifa, 3109601, Israel
-
Sandton Oncology Medical Group (Pty) Ltd-Research ( Site 4863)
Sandton, Gauteng, 2196, South Africa
-
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ( Site 4022)
Baltimore, Maryland, 21287, United States
-
The Angeles Clinic and Research Institute ( Site 4009)
Los Angeles, California, 90025, United States
-
UCLA Hematology & Oncology ( Site 4004)
Los Angeles, California, 90095, United States
-
Universitaetsspital Zuerich ( Site 4601)
Zurich, 8058, Switzerland
-
University of Colorado, Anschutz Cancer Pavilion ( Site 4012)
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.